CSPC Pharmaceutical Group (CVG) Stock Statistics & Valuation Metrics

CSPC Pharmaceutical Group has a market cap or net worth of EUR 11.02B. The enterprise value is EUR 61.00B.

Market Cap

EUR 11.02B

Enterprise Value

EUR 61.00B

CSPC Pharmaceutical Group has 11,522,452,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

11,522,452,000

Owned by Insiders

―

Owned by Institutions

11.61%

CSPC Pharmaceutical Group’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.43%.

Return on Equity (ROE)

0.11

Return on Assets (ROA)

0.08

Return on Invested Capital (ROIC)

8.43%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

1.36M

Profits Per Employee

203.03K

Employee Count

18,626

Asset Turnover

0.54

Inventory Turnover

2.82

The current PE Ratio of CSPC Pharmaceutical Group is 11.30. CSPC Pharmaceutical Group’s PEG ratio is 0.12.

PE Ratio

11.30

PS Ratio

2.71

PB Ratio

2.23

Price to FCF

6.86

Price to Operating Cash Flow

6.07

PEG Ratio

0.12

In the last 12 months, CSPC Pharmaceutical Group had revenue of 25.33B and earned 3.78B in profits. Earnings per share was 0.33.

Revenue

25.33B

Gross Profit

16.62B

Operating Income

3.87B

Pretax Income

4.68B

Net Income

3.78B

EBITDA

5.24B

Earnings Per Share (EPS)

0.33

In the last 12 months, operating cash flow was 13.78B and capital expenditures -1.57B, giving a free cash flow of 12.21B billion.

Operating Cash Flow

13.78B

Free Cash Flow

12.21B

Free Cash Flow per Share

1.07

CSPC Pharmaceutical Group pays an annual dividend of ―, resulting in a dividend yield of 3.87%

Dividend Per Share

―

Dividend Yield

3.87%

Payout Ratio

N/A

Free Cash Flow Yield

14.59%

Earnings Yield

8.75%

Beta

0.23

52-Week Price Change

16.24%

50-Day Moving Average

0.98

200-Day Moving Average

0.91

Relative Strength Index (RSI)

50.21

Average Volume (3m)

5,737

CSPC Pharmaceutical Group upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 20, 2026

Next Earnings Date

Nov 13, 2026

Ex-Dividend Date

―

CSPC Pharmaceutical Group as a current ratio of 2.19, with Debt / Equity ratio of 1.93%

Current Ratio

2.19

Quick Ratio

1.88

Debt to Market Cap

0.00

Net Debt to EBITDA

-1.04

Interest Coverage Ratio

102.89

In the past 12 months, CSPC Pharmaceutical Group has paid 907.61M in taxes.

Income Tax

907.61M

Effective Tax Rate

0.19

CSPC Pharmaceutical Group EV to EBITDA ratio is 7.44, with an EV/FCF ratio of 6.09.

EV to Sales

2.41

EV to EBITDA

7.44

EV to Free Cash Flow

6.09

EV to Operating Cash Flow

5.39

CSPC Pharmaceutical Group has EUR 18.48B in cash and marketable securities with EUR 652.37M in debt, giving a net cash position of EUR 17.83B billion.

Cash & Marketable Securities

EUR 18.48B

Total Debt

EUR 652.37M

Net Cash

EUR 17.83B

Net Cash Per Share

EUR 1.55

Tangible Book Value Per Share

EUR 3.18

Gross margin is 71.86%, with operating margin of 27.95%, and net profit margin of 23.73%.

Gross Margin

71.86%

Operating Margin

27.95%

Pretax Margin

29.45%

Net Profit Margin

23.73%

EBITDA Margin

32.38%

EBIT Margin

27.95%

The average price target for CSPC Pharmaceutical Group is EUR 1.56, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

EUR 1.56

Price Target Upside

62.23% Upside

Analyst Consensus

Strong Buy

Analyst Count

12

Revenue Growth Forecast

16.37%

EPS Growth Forecast

89.67%

Smart Score

10

AI Score

―